相似文献
1
Upholding the principles of autonomy, beneficence, and justice in phase I clinical trials.
Oncologist. 2013;18(3):242-4. doi: 10.1634/theoncologist.2013-0014. Epub 2013 Mar 1.
2
Compliance in early-phase cancer clinical trials research.
Oncologist. 2013;18(3):308-13. doi: 10.1634/theoncologist.2012-0260. Epub 2013 Mar 1.
3
A brief review of the Belmont report.
Dimens Crit Care Nurs. 2010 Jul-Aug;29(4):173-4. doi: 10.1097/DCC.0b013e3181de9ec5.
4
Preliminary ethical appraisal of a trial - what's it all about?
Duodecim. 2017;133(6):582-6.
5
Beneficence, scientific autonomy, and self-interest: ethical dilemmas in clinical research.
Camb Q Healthc Ethics. 1992 Fall;1(4):361-9. doi: 10.1017/s0963180100006551.
6
Ethical issues in clinical research.
Semin Oncol Nurs. 1989 May;5(2):102-8. doi: 10.1016/0749-2081(89)90068-5.
7
Research bioethics in the Ugandan context: a program summary.
J Law Med Ethics. 1996 Spring;24(1):47-53. doi: 10.1111/j.1748-720x.1996.tb01832.x.
8
Ethics of clinical research in patients with ALS: is there a risk of exploitation?
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):161-166. doi: 10.1080/21678421.2017.1367402. Epub 2017 Sep 4.
9
Ethical challenges in cancer care.
J Palliat Care. 1992 Spring;8(1):65-70.
10
Rethinking the Belmont Report?
Am J Bioeth. 2017 Jul;17(7):15-21. doi: 10.1080/15265161.2017.1329482.
引用本文的文献
1
Adaptation of Clinical Research Staff to Decentralized Clinical Trials and Impacts on the Patient-Centered Experience: Qualitative Interview Study.
J Med Internet Res. 2025 Jun 16;27:e62947. doi: 10.2196/62947.
2
Standard of prevention for infectious diseases' prevention clinical trials during pandemics: learning lessons for global policies from biomedical HIV prevention clinical trials and a case study of COVID-19.
Front Public Health. 2025 Jan 21;12:1539840. doi: 10.3389/fpubh.2024.1539840. eCollection 2024.
3
Collaboration in the formulation and implementation of policies for noncommunicable diseases in South Africa.
Health SA. 2023 Mar 20;28:2100. doi: 10.4102/hsag.v28i0.2100. eCollection 2023.
4
Between a rock and a hard place: Ethics, nurses' safety, and the right to protest during the COVID-19 pandemic.
Int Nurs Rev. 2021 Sep;68(3):270-278. doi: 10.1111/inr.12703.
5
Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.
Hum Vaccin Immunother. 2021 Nov 2;17(11):3843-3849. doi: 10.1080/21645515.2021.1947101. Epub 2021 Jul 15.
本文引用的文献
1
Compliance in early-phase cancer clinical trials research.
Oncologist. 2013;18(3):308-13. doi: 10.1634/theoncologist.2012-0260. Epub 2013 Mar 1.
2
Parallel anticancer drug development and molecular stratification to qualify predictive biomarkers: dealing with obstacles hindering progress.
Cancer Discov. 2011 Aug;1(3):207-12. doi: 10.1158/2159-8290.CD-11-0161.
3
Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.
Cancer. 2012 Sep 15;118(18):4571-8. doi: 10.1002/cncr.27397. Epub 2012 Jan 31.
4
Assessing the impact of protocol design changes on clinical trial performance.
Am J Ther. 2008 Sep-Oct;15(5):450-7. doi: 10.1097/MJT.0b013e31816b9027.
5
Economics of new oncology drug development.
J Clin Oncol. 2007 Jan 10;25(2):209-16. doi: 10.1200/JCO.2006.09.0803.
6
A summary of important documents in the field of research ethics.
Schizophr Bull. 2006 Jan;32(1):69-80. doi: 10.1093/schbul/sbj005. Epub 2005 Sep 28.
7
Risks and benefits of phase 1 oncology trials, 1991 through 2002.
N Engl J Med. 2005 Mar 3;352(9):895-904. doi: 10.1056/NEJMsa042220.
8
New science-based endpoints to accelerate oncology drug development.
Eur J Cancer. 2005 Mar;41(4):491-501. doi: 10.1016/j.ejca.2004.12.006. Epub 2005 Jan 22.
9
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.
JAMA. 2004 Nov 3;292(17):2130-40. doi: 10.1001/jama.292.17.2130.
Zotero 插件